Andrew Trans

Andrew Trans is an experienced professional in the field of biotechnology and software product management. Currently serving as a Senior Staff Software Product Manager at Altos Labs since June 2022, Trans leads the development of innovative products that manage research activities and data workflows. As the founder of R0 Bioscience, Inc. from January 2021 to June 2022, Trans focused on enhancing molecular diagnostic tests. Prior to this, Trans held various roles at Palantir Technologies, where data management optimization was a key focus. A substantial tenure at Roche involved roles as Principal Scientist and Senior Scientist, where Trans made significant contributions to nanopore sequencing and molecular design across international teams. Early career stages included key positions at Genia Technologies, where Trans significantly impacted DNA sequencing research. Trans holds a Bachelor of Science in Biotechnology from the University of California, Davis.